Recombinant Human β-Defensin 4/DEFB4

Recombinant Human β-Defensin 4/DEFB4

SKU: C126-10ug
Recombinant Human beta-Defensin 4 is produced by our E.coli expression system and the target gene encoding Glu23-Pro72 is expressed. Bon Opus Cat. #C126 (BP023)
  • Accession Number

  • Background

    Defensins are cationic peptides. It is an important ingredient of the innate immune system. β-defensins are expressed on some leukocytes and epithelial surfaces. Four human β-Defensins have been identified to date: BD-1, BD-2, BD-3 and BD-4. β-defensins contain a six-cysteine motif, they forms three intra-molecular disulfide bonds. β-defensins are also chemoattractant towards immature dendritic cells and memory T cells. The β-defensin proteins are expressed as the C-terminal portion of precursors; they are released by proteolytic cleavage of a signal sequence.
  • Expression

    E. coli
  • Packaging

  • Formulation

    Lyophilized from a 0.2 μm filtered solution of 20mM PB, 130mM NaCl, pH 7.4.
  • ALTnames

    Beta-Defensin 104, Beta-Defensin 4, BD-4, DEFB-4, hBD-4, Defensin Beta 104, DEFB104A, DEFB104, DEFB4, DEFB104B
  • Twitter
  • Facebook
  • LinkedIn

Terms and Conditions  I  Privacy Policy  I  Legal  I  Sitemap ©2020 by Bon Opus Biosciences, LLC.     150 Essex St, Millburn, NJ 07041, USA